Cited by

• Safety of CoronaVac and ChAdOx1 vaccines against SARS-CoV-2 in patients with rheumatoid arthritis: data from the Brazilian multicentric study safer.

  Cruz VA, Guimarães C, Rêgo J, Machado KLLL, Miyamoto ST, Burian APN, Dias LH, Pretti FZ, Batista DCFA, Mill JG, de Oliveira YGP, Gadelha CSE, da Penha Gomes Gouveia M, Moulin ACS, Souza BO, Aguiar LGR, Vieira GSS, Grillo LL, de Lima MD, Pasti LP, Surlo HF, Faé F, Moulaz IR, Macabú MO, Ribeiro PDC, Magalhães VO, de Aguiar MF, Biegelmeyer E, Peixoto FMMMC, Kayser C, de Souza AWS, de Moura Castro CH, Ribeiro SLE, Telles CMPF, Bühring J, de Lima RL, Dos Santos SHO, Dias SEB, de Melo NS, da Silva Sanches RH, Boechat AL, Sartori NS, Hax V, Dória LD, de Rezende RPV, Baptista KL, Fortes NRQ, de Melo AKG, Melo TS, de Abreu Vieira RMR, Vieira ASR, Kakehasi AM, Tavares ACFMG, de Landa AT, da Costa PVT, Azevedo VF, Martins-Filho OA, Peruhype-Magalhães V, de Medeiros Pinheiro M, Monticielo OA, Dos Reis-Neto ET, Ferreira GA, de Souza VA, Teixeira-Carvalho A, Xavier RM, Sato EI, Valim V, Pileggi GS, da Silva NA. Cruz VA, et al. Adv Rheumatol. 2024 Aug 12;64(1):58. doi: 10.1186/s42358-024-00397-5. Adv Rheumatol. 2024. PMID: 39135131 Clinical Trial.
• Long-term risk of autoimmune diseases after mRNA-based SARS-CoV2 vaccination in a Korean, nationwide, population-based cohort study.

  Jung SW, Jeon JJ, Kim YH, Choe SJ, Lee S. Jung SW, et al. Nat Commun. 2024 Jul 23;15(1):6181. doi: 10.1038/s41467-024-50656-8. Nat Commun. 2024. PMID: 39039113 Free PMC article.
• Investigation of recurrence of joint symptoms after COVID-19 in patients with rheumatoid arthritis: Cross-sectional study.

  Akbarpour A, Salesi M, Babak A. Akbarpour A, et al. J Res Med Sci. 2024 Apr 29;29:21. doi: 10.4103/jrms.jrms_782_22. eCollection 2024. J Res Med Sci. 2024. PMID: 38855563 Free PMC article.
• Factors associated with disease flare following SARS-CoV-2 vaccination in people with inflammatory rheumatic and musculoskeletal diseases: results from the physician-reported EULAR Coronavirus Vaccine (COVAX) Registry.

  Farisogullari B, Lawson-Tovey S, Hyrich KL, Gossec L, Carmona L, Strangfeld A, Mateus EF, Schäfer M, Rodrigues A, Hachulla E, Gomez-Puerta JA, Mosca M, Durez P, Trefond L, Goulenok T, Cornalba M, Stenova E, Bulina I, Strakova E, Zepa J, Roux N, Brocq O, Veillard E, Raffeiner B, Burmester GR, Mariette X, Machado PM; EULAR COVAX Registry. Farisogullari B, et al. Ann Rheum Dis. 2024 Oct 21;83(11):1584-1595. doi: 10.1136/ard-2024-225869. Ann Rheum Dis. 2024. PMID: 38816065 Free PMC article.
• Safety of COVID-19 Vaccine in Patients with Rheumatic and Musculoskeletal Diseases.

  Younis AA, Ridha AA, Humadi YA, Jassim NA, Awadh NI, Maroof A, Alqazzaz AMH, Gorial FI, Qaradaghi TA, Abdulzahra ZS, Mahmood ZA, Yaseen NT, AlIdrecy DN, Hakman IT, Tarfah SJ, Khudhair AS. Younis AA, et al. Mediterr J Rheumatol. 2024 Feb 8;35(1):123-133. doi: 10.31138/mjr.140223.sof. eCollection 2024 Mar. Mediterr J Rheumatol. 2024. PMID: 38736958 Free PMC article.